Guoji Yanke Zazhi (Apr 2020)

Progress in the treatment of uveitis

  • Xing-Xing Liao,
  • Guo-Xing Xu

DOI
https://doi.org/10.3980/j.issn.1672-5123.2020.4.11
Journal volume & issue
Vol. 20, no. 4
pp. 631 – 634

Abstract

Read online

The uveitis is a clinical common involving the iris, ciliary body, vitreous body, choroid, retina and retinal blood vessels, a group of inflammatory disease causes complex, due to the pathogenesis of uveitis did not clarify clearly, looking for effective treatment of uveitis drugs has been the main direction of ophthalmic research, in addition to the traditional glucocorticoid, cycloplegia agent, nonsteroidal anti-inflammatory drugs(nsaids), immune inhibitor has a good curative effect on uveitis, along with the development of molecular biology, a new type of biological agents, gene therapy, could fairly claim a place in the history of Chinese medicine in the treatment of uveitis. This article aims to review the latest progress in the treatment of uveitis.

Keywords